These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
219 related articles for article (PubMed ID: 34228359)
1. Periostin deficiency reduces diethylnitrosamine-induced liver cancer in mice by decreasing hepatic stellate cell activation and cancer cell proliferation. Xiao H; Zhang Y; Li Z; Liu B; Cui D; Liu F; Chen D; Liu Y; Ouyang G J Pathol; 2021 Oct; 255(2):212-223. PubMed ID: 34228359 [TBL] [Abstract][Full Text] [Related]
2. Periostin involved in the activated hepatic stellate cells-induced progression of residual hepatocellular carcinoma after sublethal heat treatment: its role and potential for therapeutic inhibition. Zhang R; Lin XH; Ma M; Chen J; Chen J; Gao DM; Cui JF; Chen RX J Transl Med; 2018 Nov; 16(1):302. PubMed ID: 30400797 [TBL] [Abstract][Full Text] [Related]
5. Periostin down-regulation attenuates the pro-fibrogenic response of hepatic stellate cells induced by TGF-β1. Hong L; Shejiao D; Fenrong C; Gang Z; Lei D J Cell Mol Med; 2015 Oct; 19(10):2462-8. PubMed ID: 26249143 [TBL] [Abstract][Full Text] [Related]
6. Cell expression patterns of CD147 in N-diethylnitrosamine/phenobarbital-induced mouse hepatocellular carcinoma. Lu M; Wu J; He F; Wang XL; Li C; Chen ZN; Bian H J Mol Histol; 2015 Feb; 46(1):79-91. PubMed ID: 25447507 [TBL] [Abstract][Full Text] [Related]
7. Activated hepatic stellate cells promote tumorigenicity of hepatocellular carcinoma. Amann T; Bataille F; Spruss T; Mühlbauer M; Gäbele E; Schölmerich J; Kiefer P; Bosserhoff AK; Hellerbrand C Cancer Sci; 2009 Apr; 100(4):646-53. PubMed ID: 19175606 [TBL] [Abstract][Full Text] [Related]
8. Persistent mTORC1 activation via Depdc5 deletion results in spontaneous hepatocellular carcinoma but does not exacerbate carcinogen- and high-fat diet-induced hepatic carcinogenesis in mice. Xu L; Yang C; Wang J; Li Z; Huang R; Ma H; Ma J; Wang Q; Xiong X Biochem Biophys Res Commun; 2021 Nov; 578():142-149. PubMed ID: 34562654 [TBL] [Abstract][Full Text] [Related]
9. Activated hepatic stellate cells secrete periostin to induce stem cell-like phenotype of residual hepatocellular carcinoma cells after heat treatment. Zhang R; Yao RR; Li JH; Dong G; Ma M; Zheng QD; Gao DM; Cui JF; Ren ZG; Chen RX Sci Rep; 2017 May; 7(1):2164. PubMed ID: 28526827 [TBL] [Abstract][Full Text] [Related]
10. Remodeling of hepatic stellate cells orchestrated the stroma-derived oxaliplatin-resistance through CCN3 paracrine in hepatocellular carcinoma. Liao X; Bu Y; Chang F; Jia F; Song G; Xiao X; Zhang M; Ning P; Jia Q BMC Cancer; 2019 Dec; 19(1):1192. PubMed ID: 31805888 [TBL] [Abstract][Full Text] [Related]
11. COL6A3-derived endotrophin links reciprocal interactions among hepatic cells in the pathology of chronic liver disease. Lee C; Kim M; Lee JH; Oh J; Shin HH; Lee SM; Scherer PE; Kwon HM; Choi JH; Park J J Pathol; 2019 Jan; 247(1):99-109. PubMed ID: 30246318 [TBL] [Abstract][Full Text] [Related]
12. Activated hepatic stellate cells promote hepatocellular carcinoma development in immunocompetent mice. Zhao W; Zhang L; Yin Z; Su W; Ren G; Zhou C; You J; Fan J; Wang X Int J Cancer; 2011 Dec; 129(11):2651-61. PubMed ID: 21213212 [TBL] [Abstract][Full Text] [Related]
13. DJ-1 promotes development of DEN-induced hepatocellular carcinoma and proliferation of liver cancer cells. Qiu B; Wang J; Yu Y; Zhen C; Gu J; Liu W; Wen Y; Chen L; Gao Y; Xia Q; Kong X Oncotarget; 2017 Jan; 8(5):8499-8511. PubMed ID: 28036277 [TBL] [Abstract][Full Text] [Related]
14. Paracrine activation of hepatic stellate cells in platelet-derived growth factor C transgenic mice: evidence for stromal induction of hepatocellular carcinoma. Wright JH; Johnson MM; Shimizu-Albergine M; Bauer RL; Hayes BJ; Surapisitchat J; Hudkins KL; Riehle KJ; Johnson SC; Yeh MM; Bammler TK; Beyer RP; Gilbertson DG; Alpers CE; Fausto N; Campbell JS Int J Cancer; 2014 Feb; 134(4):778-88. PubMed ID: 23929039 [TBL] [Abstract][Full Text] [Related]
15. Fasting inhibits hepatic stellate cells activation and potentiates anti-cancer activity of Sorafenib in hepatocellular cancer cells. Lo Re O; Panebianco C; Porto S; Cervi C; Rappa F; Di Biase S; Caraglia M; Pazienza V; Vinciguerra M J Cell Physiol; 2018 Feb; 233(2):1202-1212. PubMed ID: 28471474 [TBL] [Abstract][Full Text] [Related]
16. JCAD deficiency attenuates activation of hepatic stellate cells and cholestatic fibrosis. Xie L; Chen H; Zhang L; Ma Y; Zhou Y; Yang YY; Liu C; Wang YL; Yan YJ; Ding J; Teng X; Yang Q; Liu XP; Wu J Clin Mol Hepatol; 2024 Apr; 30(2):206-224. PubMed ID: 38190829 [TBL] [Abstract][Full Text] [Related]
17. The glypican 3 hepatocellular carcinoma marker regulates human hepatic stellate cells via Hedgehog signaling. Magistri P; Leonard SY; Tang CM; Chan JC; Lee TE; Sicklick JK J Surg Res; 2014 Apr; 187(2):377-85. PubMed ID: 24439425 [TBL] [Abstract][Full Text] [Related]
18. Matrix stiffness modulates hepatic stellate cell activation into tumor-promoting myofibroblasts via E2F3-dependent signaling and regulates malignant progression. Liu Z; Mo H; Liu R; Niu Y; Chen T; Xu Q; Tu K; Yang N Cell Death Dis; 2021 Dec; 12(12):1134. PubMed ID: 34873170 [TBL] [Abstract][Full Text] [Related]
19. Periostin promotes liver fibrogenesis by activating lysyl oxidase in hepatic stellate cells. Kumar P; Smith T; Raeman R; Chopyk DM; Brink H; Liu Y; Sulchek T; Anania FA J Biol Chem; 2018 Aug; 293(33):12781-12792. PubMed ID: 29941453 [TBL] [Abstract][Full Text] [Related]
20. Pregnane X receptor inhibits the transdifferentiation of hepatic stellate cells by down-regulating periostin expression. Sato T; Shizu R; Baba R; Ooka A; Hosaka T; Kanno Y; Yoshinari K Biochem J; 2024 Sep; 481(18):1173-1186. PubMed ID: 39171361 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]